Bone Biologics (BBLG) vs Cuprina (Cayman) (CUPR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Cuprina (Cayman) is the larger company by market cap ($13.4 million vs $1.3 million), about 10.4 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | BBLG | CUPR |
|---|---|---|
| Share price | $0.468 | $1.91 |
| Market cap | $1.29M | $13.38M |
| 1-day change | -4.00% | -4.02% |
| YTD return | — | -37.81% |
| 1-year return | — | -77.39% |
| EPS (TTM) | $-1.37 | $-1.40 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.79 | $14.80 |
| 52-week low | $0.428 | $1.45 |
| Distance from 52-week high | -83.23% | -87.09% |
| Average volume | 378.57K | 94.72K |
| Shares outstanding | 2.76M | 5.24M |
| Sector | Health Care | Health Care |
| Industry | Industrial Specialties | Industrial Specialties |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Cuprina (Cayman) is about 10.4 times larger than Bone Biologics by market value ($13.38M vs $1.29M).
BBLG vs CUPR FAQ
Which is bigger, Bone Biologics or Cuprina (Cayman)?
Cuprina (Cayman) (CUPR) is larger, with a market capitalization of $13.38M compared with $1.29M for Bone Biologics (BBLG).
Are Bone Biologics and Cuprina (Cayman) in the same industry?
Yes. Both are classified in the Industrial Specialties industry within the Health Care sector.